推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 國(guó)務(wù)院法制辦網(wǎng)站21日公布了《進(jìn)出境中藥材檢疫監(jiān)督管理辦法(公開征求意見稿)》。意見稿擬規(guī)定，檢驗(yàn)檢疫部門應(yīng)當(dāng)將進(jìn)出境中藥材的貨主或者其代理人以及境內(nèi)外生產(chǎn)企業(yè)納入誠信管理。同時(shí)，意見稿還明確了企業(yè)的信息報(bào)告義務(wù)。
意見稿提出，進(jìn)境中藥材的貨主或者其代理人和出境生產(chǎn)企業(yè)應(yīng)當(dāng)建立疫情信息報(bào)告制度和應(yīng)急處置方案。發(fā)現(xiàn)疫情信息應(yīng)當(dāng)及時(shí)向檢驗(yàn)檢疫部門報(bào)告并積極配合檢驗(yàn)檢疫部門進(jìn)行疫情處置。
對(duì)于引起重大動(dòng)植物疫情的以及偽造、變?cè)鞕z驗(yàn)檢疫單證、印章、標(biāo)志、封識(shí)的兩種情形，意見稿提出，依法追究刑事責(zé)任；尚不構(gòu)成犯罪或者犯罪情節(jié)顯著輕微依法不需要判處刑罰的，由口岸動(dòng)植物檢疫機(jī)關(guān)處2萬元以上5萬元以下的罰款。
針對(duì)申報(bào)虛假用途行為，意見稿擬規(guī)定，進(jìn)出境中藥材貨主或者其代理人，存在未報(bào)檢或者未依法辦理檢疫審批手續(xù)或者未按檢疫審批的規(guī)定執(zhí)行的；報(bào)檢的中藥材與實(shí)際不符的，由口岸動(dòng)植物檢疫機(jī)關(guān)處5000元以下的罰款；已取得檢疫單證的，予以吊銷。
根據(jù)意見稿，未經(jīng)檢驗(yàn)檢疫部門許可擅自將進(jìn)境中藥材卸離運(yùn)輸工具或者運(yùn)遞的；擅自開拆、損毀動(dòng)植物檢疫封識(shí)或者標(biāo)志的，由口岸動(dòng)植物檢疫機(jī)關(guān)處3000元以上3萬元以下的罰款。
意見稿強(qiáng)調(diào)，檢驗(yàn)檢疫部門工作人員在對(duì)進(jìn)出境中藥材實(shí)施檢疫和監(jiān)督管理工作中濫用職權(quán)，故意刁難當(dāng)事人的，徇私舞弊，偽造檢驗(yàn)檢疫結(jié)果的，或者玩忽職守，延誤檢驗(yàn)檢疫出證的，依法給予行政處分；構(gòu)成犯罪的，依法追究刑事責(zé)任。
